Trending in drug discovery at SLAS2020

Melanie Leveridge, SLAS2020 Co-Chair and Head of Screening, Profiling & Mechanistic Biology, GSK (UK), highlights the hot drug discovery trends which captured imaginations at this year’s SLAS meeting, from automation to cellular target engagement.

This interview was filmed at SLAS2020 - watch other highlights from the show here >>